Vitamin D affects the risk of disease activity in multiple sclerosis

Antonino Giordano; Ferdinando Clarelli; Béatrice Pignolet; Elisabetta Mascia; Melissa Sorosina; Kaalindi Misra; Laura Ferrè; Florence Bucciarelli; Ali Manouchehrinia; Lucia Moiola; Vittorio Martinelli; Maria A. Rocca; Roland Liblau; Massimo Filippi; Federica Esposito

doi:10.1136/jnnp-2024-334062

Abstract

1 min read

VitD levels before DMT start affect the risk of disease activity in MS. Genetic predisposition to higher VitD levels confers a lower risk of disease activity and is associated with delayed MS onset. Our work prompts future prospective studies regarding VitD supplementation and lifestyle interventions to hamper disease activity in MS.

Related publications

Article2022

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa, María Trojano

Article2021

The determinants and longitudinal changes in vitamin D status in middle-age: a Northern Finland Birth Cohort 1966 study

Helmi Ikonen, Johanna Lumme, Jussi Seppälä, Paula Pesonen, Terhi Piltonen, Paul M Ridker, Karl‐Heinz Herzig, Jouko Miettunen, Maarit Niinimäki, Saranya Palaniswamy, Sylvain Sebért, Marja Ojaniemi

Article2014

Effect of vitamin D on insulin resistance and tissue inflammation in western and control diet‐fed mice (1108.7)

Shivaprakash Jagalur Mutt, Ghulam Shere Raza, Toni Karhu, Sirkka Keinänen‐Kiukaanniemi, Paul M Ridker, Karl‐Heinz Herzig

Article2023

Vitamin D and Metabolic Syndrome in Working Age Subjects from an Obesity Clinic

Luisella Vigna, Michela Carola Speciani, Amedea Silvia Tirelli, Francesca Bravi, Carlo La Vecchia, Caterina Conte, F. Gori

Article2016

Effect of Vitamin D on Adipogenesis under Hypoxia

Shivaprakash Jagalur Mutt, Siri Lehtonen, Petri Lehenkari, Juhani Leppäluoto, Paul M Ridker, Karl‐Heinz Herzig